1. Home
  2. VKTX vs HBM Comparison

VKTX vs HBM Comparison

Compare VKTX & HBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • HBM
  • Stock Information
  • Founded
  • VKTX 2012
  • HBM 1927
  • Country
  • VKTX United States
  • HBM Canada
  • Employees
  • VKTX N/A
  • HBM N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • HBM Metal Mining
  • Sector
  • VKTX Health Care
  • HBM Basic Materials
  • Exchange
  • VKTX Nasdaq
  • HBM Nasdaq
  • Market Cap
  • VKTX 2.8B
  • HBM 2.9B
  • IPO Year
  • VKTX 2015
  • HBM N/A
  • Fundamental
  • Price
  • VKTX $27.55
  • HBM $7.69
  • Analyst Decision
  • VKTX Buy
  • HBM Hold
  • Analyst Count
  • VKTX 12
  • HBM 1
  • Target Price
  • VKTX $84.00
  • HBM $14.00
  • AVG Volume (30 Days)
  • VKTX 4.3M
  • HBM 5.6M
  • Earning Date
  • VKTX 04-23-2025
  • HBM 05-12-2025
  • Dividend Yield
  • VKTX N/A
  • HBM 0.19%
  • EPS Growth
  • VKTX N/A
  • HBM N/A
  • EPS
  • VKTX N/A
  • HBM 0.20
  • Revenue
  • VKTX N/A
  • HBM $2,021,200,000.00
  • Revenue This Year
  • VKTX N/A
  • HBM $8.05
  • Revenue Next Year
  • VKTX N/A
  • HBM $0.87
  • P/E Ratio
  • VKTX N/A
  • HBM $38.45
  • Revenue Growth
  • VKTX N/A
  • HBM 19.60
  • 52 Week Low
  • VKTX $18.92
  • HBM $5.95
  • 52 Week High
  • VKTX $81.81
  • HBM $10.49
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 53.68
  • HBM 56.82
  • Support Level
  • VKTX $26.37
  • HBM $6.98
  • Resistance Level
  • VKTX $30.28
  • HBM $7.70
  • Average True Range (ATR)
  • VKTX 1.65
  • HBM 0.23
  • MACD
  • VKTX 0.27
  • HBM 0.06
  • Stochastic Oscillator
  • VKTX 56.53
  • HBM 90.78

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About HBM Hudbay Minerals Inc. (Canada)

Hudbay Minerals Inc is a Canadian mining company with its operations, property developments, and exploration activities across the United States. The mines that Hudbay operates are located in Manitoba, Canada, Arizona, United States; and Peru. The company is principally focused on the discovery, production, and marketing of base and precious metals. Hudbay produces copper concentrate, which contains copper, gold, and silver, as well as zinc metal. More than half the company's revenue is attributable to the copper business. The company sells copper concentrates to smelters across Asia, America, and Europe, and sells Zinc metal, another source of revenue, to industrial customers across North America.

Share on Social Networks: